Adrenal androgens in the polycystic ovary syndrome
- Ricardo Azziz(corresponding author)
- Cedars-Sinai Medical Center,
- University of Alabama at Birmingham
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>The polycystic ovary syndrome (PCOS) is one of the most common human endocrine abnormalities, affecting 4% to 6% of reproductive-aged women. Although patients with PCOS primarily demonstrate excess production of ovarian androgens, elevated adrenal androgen (AA) levels, primarily dehydroepiandrosterone sulfate (DHEAS), are observed in 20 to 30% of patients if age-related normative values are used. Adrenal androgens may contribute to the phenotype of PCOS, including the development of hirsutism. Overall the cause(s) of the excess AAs levels in PCOS remains unclear. Adrenal androgen levels in PCOS appear to be determined, at least in part, by extra-adrenal factors such as ovarian steroids and insulin. Nonetheless, the primary effect of extra-adrenal androgens and insulin appears to be increased sulfotransferase activity, augmenting the conversion of DHEA to DHEAS. In fact most studies have demonstrated a limited role for extra-adrenal factors in the regulation of circulating AA levels in vivo. Primarily, AAs and AA excess in PCOS (and in normal subjects) appear to be under significant genetic control. Hence, it is possible that AA excess in PCOS may reflect an inherited abnormality of steroidogenesis. However, and consistent with the significant degree of populational heterogeneity observe in AA levels and secretion, it is more probable that the elevated AA levels found in patients with PCOS may actually reflect selection bias, with a disproportionate number of the women with the highest levels of AAs also having the greatest prevalence of PCOS. In essence, elevated AA secretion in women may reflect an exaggerated AA secretion in response to adrenocorticotrophic hormone (ACTH) stimulation, and may be a predisposing risk factor for the development of PCOS.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 469-474 (6 pages)Journal (Volume, Issue Number)
Current Opinion in Endocrinology and Diabetes (Volume 9, Issue 6)Publication milestones
- Published - 12/2002
Publication status
Published - 12/2002
ISSN
1068-3097Publication IDs
- Scopus: 0038687048
Publication metrics
Metrics
SciVal
FWCI
0.08
SciVal
Author count
1
SciVal
citations
1
SciVal
Paper percentile
33
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
5
Citation count
1
